The Genomics of Congenital Diaphragmatic Hernia: A 10-Year Retrospective Review

K Taylor Wild1, Erica Schindewolf2, Holly L Hedrick3

  • 1Division of Neonatology, The Children's Hospital of Philadelphia, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA; Division of Human Genetics, The Children's Hospital of Philadelphia, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA; Roberts Individualized Medical Genetics Center, The Children's Hospital of Philadelphia, Philadelphia, PA.

Insights

Genetic testing is valuable for infants with congenital diaphragmatic hernia (CDH), especially complex cases. Further genomic studies are needed to improve diagnosis and management for all CDH infants.

Area of Science:

  • Genetics
  • Pediatrics
  • Medical Diagnostics

Background:

  • Congenital diaphragmatic hernia (CDH) is a complex birth defect.
  • Genetic factors play a significant role in CDH, influencing prognosis and management.
  • Understanding genetic testing utility is crucial for optimizing care in infants with CDH.

Purpose of the Study:

  • To evaluate the utilization and diagnostic yield of genetic testing in infants with CDH over a 10-year period.
  • To inform future practices and personalize prognostication and management strategies for CDH patients.
  • To assess the effectiveness of different genetic testing modalities in identifying etiologies.

Main Methods:

  • Retrospective cohort study of infants with CDH.
  • Analysis of demographic, prenatal, and postnatal data.
  • Review of genetic testing results, including microarray and exome sequencing.

Main Results:

  • Genetic testing was diagnostic in 14% of all infants with CDH.
  • Diagnostic rates were significantly higher in complex/syndromic (57%) versus isolated/nonsyndromic (2%) CDH cases.
  • Mortality was higher in complex/syndromic infants and those who underwent genetic testing.

Conclusions:

  • Comprehensive genetic testing demonstrates utility in infants with CDH, particularly complex cases.
  • A significant proportion of CDH cases, especially isolated ones, lack identified genetic etiologies.
  • Further genomic research is essential to enhance diagnostic rates and enable individualized management for CDH.
Abstract